United States

Natera Inc (NTRA)

Track

Over the past 90 days, Natera Inc. insiders have engaged in 178 transactions, all of which were sales, totaling approximately $160.6 million in value. These divestments occurred as the stock price rose 25.7%. Following the May 2026 results financiers, multiple officers and directors, including the CEO, have executed planned and proposed sales of company shares.
Ticker: NTRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Natera Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 7 Aug 2026
Value US$689,305.96 | Price 180.37 | Shares 40,705
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-07 PrS Proposed sale
2.1
Sheena Jonathan

Director

Non-Executive Director
40,705
180.37
US$689,306 		40,705 180.37 US$689,306
2026-08-05 2026-08-04 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
71,017 +43.4%
338.18
US$4,757,492 		71,017 +43.4% 338.18 US$4,757,492
2026-08-04 2026-08-04 PrS Proposed sale
2.1
MICHAEL BROPHY

Officer

Officer
88,767
112.51
US$507,462 		88,767 112.51 US$507,462
2026-08-05 2026-08-03 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.0%
267.99
US$100,000 		1,000 -0.0% 267.99 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Rabinowitz Matthew

EXECUTIVE CHAIRMAN

Executive Director
1,000 -0.0%
267.99
US$100,000 		1,000 -0.0% 267.99 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
1,000 -0.2%
267.99
US$100,000 		1,000 -0.2% 267.99 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -0.6%
268.22
US$100,000 		1,000 -0.6% 268.22 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -0.3%
267.08
US$100,000 		1,000 -0.3% 267.08 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -0.1%
265.27
US$100,000 		1,000 -0.1% 265.27 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -0.7%
263.86
US$100,000 		1,000 -0.7% 263.86 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -0.1%
261.03
US$100,000 		1,000 -0.1% 261.03 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -0.2%
259.98
US$100,000 		1,000 -0.2% 259.98 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -1.1%
267.99
US$100,000 		1,000 -1.1% 267.99 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
RABINOWITZ DANIEL

SEC. AND CHIEF LEGAL OFFICER

Officer
1,000 -0.2%
267.99
US$100,000 		1,000 -0.2% 267.99 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.1%
268.70
US$100,000 		1,000 -0.1% 268.70 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.9%
267.79
US$100,000 		1,000 -0.9% 267.79 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.1%
265.28
US$100,000 		1,000 -0.1% 265.28 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.7%
263.94
US$100,000 		1,000 -0.7% 263.94 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.2%
261.49
US$100,000 		1,000 -0.2% 261.49 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.2%
259.98
US$100,000 		1,000 -0.2% 259.98 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.3%
267.99
US$100,000 		1,000 -0.3% 267.99 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -0.6%
267.99
US$100,000 		1,000 -0.6% 267.99 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.4
MATTHEW RABINOWITZ

OFFICER; DIRECTOR

Executive Director
1,000
267.76
US$100,000 		1,000 267.76 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.1
JONATHAN SHEENA

OFFICER

Officer
1,000
267.76
US$100,000 		1,000 267.76 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.1
MICHAEL BROPHY

OFFICER

Officer
1,000
267.76
US$100,000 		1,000 267.76 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
DANIEL RABINOWITZ

OFFICER

Officer
1,000
267.76
US$100,000 		1,000 267.76 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
JOHN FESKO

OFFICER

Officer
1,000
267.76
US$100,000 		1,000 267.76 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

OFFICER

Officer
1,000
267.76
US$100,000 		1,000 267.76 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.1
STEVEN CHAPMAN

OFFICER; DIRECTOR

Executive Director
1,000
267.76
US$100,000 		1,000 267.76 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.1
STEVEN L CHAPMAN

Officer; Director

Executive Director
1,000
265.40
US$100,000 		1,000 265.40 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

Officer

Officer
1,000
265.25
US$100,000 		1,000 265.25 US$100,000
2026-07-29 2026-07-29 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -3.4%
249.38
US$100,000 		1,000 -3.4% 249.38 US$100,000
2026-07-29 2026-07-29 PrS Proposed sale
2.1
MICHAEL BROPHY

Officer

Officer
1,000
252.22
US$100,000 		1,000 252.22 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
RABINOWITZ DANIEL

SEC. AND CHIEF LEGAL OFFICER

Officer
1,000 -0.6%
254.07
US$100,000 		1,000 -0.6% 254.07 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.9%
254.07
US$100,000 		1,000 -0.9% 254.07 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -0.3%
254.33
US$100,000 		1,000 -0.3% 254.33 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -1.8%
253.77
US$100,000 		1,000 -1.8% 253.77 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -2.2%
254.07
US$100,000 		1,000 -2.2% 254.07 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
1,000 -0.5%
254.07
US$100,000 		1,000 -0.5% 254.07 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -3.4%
254.07
US$100,000 		1,000 -3.4% 254.07 US$100,000
2026-07-29 2026-07-28 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
254.07
US$100,000 		1,000 -0.1% 254.07 US$100,000
2026-07-28 2026-07-28 PrS Proposed sale
2.1
MICHAEL BROPHY

Officer

Officer
1,000
258.03
US$100,000 		1,000 258.03 US$100,000
2026-07-28 2026-07-28 PrS Proposed sale
2.1
JONATHAN SHEENA

DIRECTOR

Non-Executive Director
1,000
258.03
US$100,000 		1,000 258.03 US$100,000
2026-07-28 2026-07-28 PrS Proposed sale
JOH N FESKO

OFFICER

Officer
1,000
258.03
US$100,000 		1,000 258.03 US$100,000
2026-07-28 2026-07-28 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

OFFICER

Officer
1,000
258.03
US$100,000 		1,000 258.03 US$100,000
2026-07-28 2026-07-28 PrS Proposed sale
2.1
STEVEN CHAPMAN

OFFICER; DIRECTOR

Executive Director
1,000
258.03
US$100,000 		1,000 258.03 US$100,000
2026-07-28 2026-07-28 PrS Proposed sale
2.1
MICHAEL BROPHY

OFFICER

Officer
1,000
258.03
US$100,000 		1,000 258.03 US$100,000
2026-07-28 2026-07-28 PrS Proposed sale
DANIEL RABINOWITZ

OFFICER

Officer
1,000
258.03
US$100,000 		1,000 258.03 US$100,000
2026-07-29 2026-07-27 PlS Planned sale
RABINOWITZ DANIEL

SEC. AND CHIEF LEGAL OFFICER

Officer
1,000 -0.5%
260.49
US$100,000 		1,000 -0.5% 260.49 US$100,000
2026-07-29 2026-07-27 PlS Planned sale
2.4
Moshkevich Solomon

PRESIDENT, CLINICALDIAGNOSTICS

Officer
1,000 -0.8%
260.49
US$100,000 		1,000 -0.8% 260.49 US$100,000
2026-07-29 2026-07-27 PlS Planned sale
2.1
Brophy Michael Burkes

CHIEF FINANCIAL OFFICER

Officer
1,000 -1.4%
260.49
US$100,000 		1,000 -1.4% 260.49 US$100,000
2026-07-29 2026-07-27 PlS Planned sale
Fesko John

PRESIDENT, CHIEF BUS. OFFICER

Officer
1,000 -0.4%
260.49
US$100,000 		1,000 -0.4% 260.49 US$100,000
2026-07-29 2026-07-27 PlS Planned sale
2.1
Chapman Steven Leonard

CEO AND PRESIDENT

Executive Director
1,000 -2.0%
260.49
US$100,000 		1,000 -2.0% 260.49 US$100,000
2026-07-29 2026-07-27 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.1%
260.49
US$100,000 		1,000 -0.1% 260.49 US$100,000
2026-07-29 2026-07-27 PlS Planned sale
2.4
Rabinowitz Matthew

EXECUTIVE CHAIRMAN

Executive Director
1,000 -0.1%
260.49
US$100,000 		1,000 -0.1% 260.49 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
2.1
STEVEN CHAPMAN

OFFICER; DIRECTOR

Executive Director
1,000
261.99
US$100,000 		1,000 261.99 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
2.1
MICHAEL BROPHY

OFFICER

Officer
1,000
261.99
US$100,000 		1,000 261.99 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
DANIEL RABINOWITZ

OFFICER

Officer
1,000
261.99
US$100,000 		1,000 261.99 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
JOHN FESKO

OFFICER

Officer
1,000
261.99
US$100,000 		1,000 261.99 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
2.4
SOLOMON MOSHKEVICH

OFFICER

Officer
1,000
261.99
US$100,000 		1,000 261.99 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
2.4
MATTHEW RABINOWITZ

DIRECTOR; OFFICER

Executive Director
1,000
261.99
US$100,000 		1,000 261.99 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
2.1
JONATHAN SHEENA

DIRECTOR

Non-Executive Director
1,000
261.99
US$100,000 		1,000 261.99 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.4%
276.02
US$100,000 		1,000 -0.4% 276.02 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -1.0%
274.99
US$100,000 		1,000 -1.0% 274.99 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.5%
273.68
US$100,000 		1,000 -0.5% 273.68 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -2.1%
273.01
US$100,000 		1,000 -2.1% 273.01 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.2%
276.38
US$100,000 		1,000 -0.2% 276.38 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.9%
275.26
US$100,000 		1,000 -0.9% 275.26 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -0.5%
274.26
US$100,000 		1,000 -0.5% 274.26 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
1,000 -2.4%
273.05
US$100,000 		1,000 -2.4% 273.05 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
3.1
Chapman Rowan E
Non-Executive Director
1,000 -2.8%
274.82
US$100,000 		1,000 -2.8% 274.82 US$100,000
2026-07-15 2026-07-15 PrS Proposed sale
3.1
ROWAN EMMA CHAPMAN

Director

Non-Executive Director
135
274.82
US$37,101 		135 274.82 US$37,101
2026-07-15 2026-07-15 PrS Proposed sale
2.1
Sheena Jonathan

Director

Non-Executive Director
1,500
275.22
US$412,830 		1,500 275.22 US$412,830
2026-07-15 2026-07-13 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
500 -0.2%
268.39
US$134,194 		500 -0.2% 268.39 US$134,194
2026-07-15 2026-07-13 PlS Planned sale
2.1
Sheena Jonathan
Non-Executive Director
450 -0.2%
267.72
US$120,475 		450 -0.2% 267.72 US$120,475
Explore more

More insider trading research around Natera Inc

More insider trades in United States
Insider trading in North America